Dietary caloric restriction modifies inflammatory responses in the livers of streptozotocin-induced diabetic rats

Nutrition Research

Volumn 26, Issue 5, 2006, Pages 221-226

  Ugochukwu, Ngozi H ^a   Figgers, Cynthia L ^a  

^a FLORIDA A AND M UNIVERSITY   (United States)

Author keywords

Caloric restriction; Haptoglobin; Inflammation; Interleukins; Streptozotocin induced diabetic rats; TNF

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; HAPTOGLOBIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CALORIC RESTRICTION; CONTROLLED STUDY; DIET RESTRICTION; DOWN REGULATION; GLYCEMIC CONTROL; INFLAMMATION; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES; UPREGULATION;

ANIMALIA; RATTUS NORVEGICUS;

EID: 33746185764     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2006.05.003     Document Type: Article

References (52)

1. Moldoveanu E., Tanaseanu C., Tanaseanuv S., et al. Plasma markers of endothelial dysfunction in type 2 diabetics. Eur J Int Med 17 (2006) 38-42
2. Tataranni P.A. Relationship between subclinical inflammation, obesity, diabetes and related disorders. Drug Discov Today: Disease Mechanisms 2 (2005) 303-306
3. Pengal R.A., Ganesan L.P., Wei G., Fang H., Ostrowski M.C., and Tridandapani S. Lipopolysaccharide-induced production of interleukin-10 is promoted by the serine/threonine kinase Akt. Mol Immunol 43 (2006) 1557-1564
4. Cohen J. The immunopathogenesis of sepsis. Nature 420 (2002) 885-891
5. Schmidt M.I., Duncan B.B., Sharrett A.R., et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 353 (1999) 1649-1652
6. Moshage H. Cytokines and the hepatic acute phase response. J Pathol 181 (1997) 257-266
7. Vieira E.C., Carneiro E.M., Latorraca M.Q., et al. Low protein diet confers resistance to the inhibitory effects of interleukin 1β on insulin secretion in pancreatic islets. J Nutr Biochem 12 (2001) 285-291
8. Lagathu C., Bastard J.P., Auclair M., Maachi M., Capeau J., and Caron M. Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone. Biochem Biophys Res Commun 311 (2003) 372-379
9. Giannopoulou I., Fernhall B., Carhart R., et al. Effects of diet and/or exercise on the adipocytokine and inflammatory cytokine levels of postmenopausal women with type 2 diabetes. Metabolism 54 (2005) 866-875
10. Ugochukwu N.H., Bagayoko N.D., and Antwi M.E. The effects of dietary caloric restriction on antioxidant status and lipid peroxidation in mild and severe streptozotocin-induced diabetic rats. Clin Chim Acta 348 (2004) 121-129
11. Simonen P., Gulling H., and Miettinen T.A. Acute effects of weight reduction on cholesterol metabolism in obese type 2 diabetes. Clin Chim Acta 316 (2002) 55-61
12. Wegge J.K., Roberts C.K., Ngo T.H., and Barnard R.J. Effect of diet and exercise intervention on inflammatory and adhesion molecules in post-menopausal women on hormone replacement therapy and at risk for coronary artery disease. Metabolism 53 (2004) 377-381
13. Mattson M.P., and Wan R. Beneficial effects of intermittent fasting and caloric restriction on the cardiovascular and cerebrovascular systems. J Nutr Biochem 16 (2005) 129-137
14. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346 (2002) 393-403
15. Núñez A., Gómez-Villamandos J.C., Sánchez-Cordón P.J., et al. Expression of proinflammatory cytokines by hepatic macrophages in acute classical swine fever. J Comp Pathol 133 (2005) 23-32
16. Carrasco L., Núñez A., Salguero F.J., et al. African swine fever: expression of interleukin-1 alpha and tumour necrosis factor-alpha by pulmonary intravascular macrophages. J Comp Pathol 126 (2002) 194-201
17. Omoigui S. Cholesterol synthesis is the trigger and isoprenoid dependent interleukin-6 mediated inflammation is the common causative factor and therapeutic target for atherosclerotic vascular disease and age-related disorders including osteoporosis and type 2 diabetes. Med Hypotheses 65 (2005) 559-569
18. Gumieniczek A., Hopkała H., Roliñski J., and Bojarska-Junak A. Antioxidative and anti-inflammatory effects of repaglinide in plasma of diabetic animals. Pharmacol Res 52 (2005) 162-166
19. Lo H.C., Lin S.C., and Wang Y.M. The relationship among serum cytokines, chemokine, nitric oxide, and leptin in children with type 1 diabetes mellitus. Clin Biochem 37 (2004) 666-672
20. Morales A., García-Ruiz C., Miranda M., et al. Tumor necrosis factor increases hepatocellular glutathione by transcriptional regulation of the heavy subunit chain of γ-glutamylcysteine synthetase. J Biol Chem 272 (1997) 30371-30379
21. Avogaro A., and de Kreutzenberg S.V. Mechanisms of endothelial dysfunction in obesity. Clin Chim Acta 360 (2005) 9-26
22. Yin W., Liao D., Wang Z., et al. NO-1886 inhibits size of adipocytes, suppresses plasma levels of tumor necrosis factor-α and free fatty acids, improves glucose metabolism in high-fat/high-sucrose-fed miniature pigs. Pharmacol Res 49 (2004) 199-206
23. Kanemaki T., Kitade H., Kaibori M., et al. Interleukin 1β and interleukin 6, but not tumor necrosis factor α, inhibit insulin-stimulated glycogen synthesis in rat hepatocytes. Hepatology 27 (1998) 1296-1303
24. Fernandez-Real J.M., Vayreda M., Richart C., et al. Interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab 86 (2001) 1154-1159
25. Mohamed-Ali V., Goodrick S., Rawesh A., et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo. J Clin Endocrinol Metab 82 (1997) 4196-4200
26. Cai D., Yuan M., Frantz D.F., et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB. Nat Med 11 (2005) 183-190
27. Flower L., Gray R., Pinkney J., and Mohamed-Ali V. Stimulation of interleukin-6 release by interleukin-1β from isolated human adipocytes. Cytokines 21 (2003) 32-37
28. St-Pierre A.C., Cantin B., Bergeron J., et al. Inflammatory markers and long-term risk of ischemic heart disease in men: a 13-year follow-up of the Quebec Cardiovascular study. Atherosclerosis 182 (2005) 315-321
29. Delaney C.A., Pavlovic D., Hoorens A., Pipeleers D.G., and Eizirik D.L. Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells. Endocrinology 138 (1997) 2610-2614
30. Southern C., Schulster D., and Green I.C. Inhibition of insulin secretion by interleukin-1β and tumour necrosis factor-α via an l-arginine-dependent nitric oxide generating mechanism. FEBS Lett 276 (1990) 42-44
31. Park C., Kim J.R., Shim J.K., et al. Inhibitory effects of streptozotocin, tumor necrosis factor-α, and interleukin-1β on glucokinase activity in pancreatic islets and gene expression of GLUT2 and glucokinase. Arch Biochem Biophys 362 (1999) 217-224
32. Urata Y., Yamamotos H., Goto S., et al. Long exposure to high glucose concentration impairs the responsive expression of γ-glutamylcysteine synthase by interleukin-1β and tumor necrosis factor-α in mouse endothelial cells. J Biol Chem 271 (1996) 15146-15152
33. Eizirik D.L., Welsh N., and Hellerstrom C. Predominance of stimulatory effects of interleukin-1 beta on isolated human pancreatic islets. J Clin Endocrinol Metab 76 (1993) 399-403
34. Halliwell B., and Gutteridge J. Free radicals in biology and medicine. 2nd ed. (1989), Oxford, New York
35. Lee M., Han S., Soo Ko K., and Kim S.W. Cell type specific and glucose responsive expression of interleukin-4 by using insulin promoter and water soluble lipopolymer. J Control Release 75 (2001) 421-429
36. Robb B.W., Hershko D.D., Paxton J.H., Luo G.J., and Hasselgren P.O. Interleukin-10 activates the transcription factor C/EBP and the interleukin-6 gene promoter in human intestinal epithelial cells. Surgery 132 (2002) 226-231
37. Mocellin S., Marincola F., Rossi C.R., and Nitti D.M. The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle. Cytokine Growth Factor Rev 15 (2004) 61-76
38. Rabinovitch A., and Suarez-Pinzon W.L. Role of cytokines in the pathogenesis of autoimmune diabetes mellitus. Rev Endocr Metab Disord 4 (2003) 291-299
39. Tominaga Y., Nagata M., Yasuda H., et al. Administration of IL-4 prevents autoimmune diabetes but enhances pancreatic insulitis in NOD mice. Clin Immunol Immunopathol 86 (1998) 209-218
40. Simon G.G., Schwartz F., Wasserfall C., and Atkinson M.A. A dichotomous role for interleukin-10 in the pathogenesis of type 1 diabetes. Mol Ther 11 (2005) 353-354
41. Mueller R., Krahl T., and Sarvetnick N. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice. J Exp Med 184 (1996) 1093-1099
42. Horiki M., Yamato E., Noso S., Ikegami H., Ogihara T., and Miyazaki J. High-level expression of interleukin-4 following electroporation-mediated gene transfer accelerates type 1 diabetes in NOD mice. J Autoimmun 20 (2003) 111-117
43. Asadullah K., Sabat R., Wiese A., Döcke W.D., Volk H.D., and Sterry W. Interleukin-10 in cutaneous disorders: implications for its pathophysiological importance and therapeutic use. Arch Dermatol Res 291 (1999) 628-636
44. Takada M., Toyama H., Tanaka T., Suzuki Y., and Kuroda Y. Augmentation of interleukin-10 in pancreatic islets after brain death. Transplant Proc 36 (2004) 1534-1536
45. Howard M., Muchamuel T., Andrade S., and Menon S. Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 177 (1993) 1205-1208
46. Braeckman L., De Bacquer D., Delanghe J., Claeys L., and De Backer G. Associations between haptoglobin polymorphism, lipids, lipoproteins and inflammatory variables. Atherosclerosis 143 (1999) 383-388
47. Friedrichs W.E., Navarijoashbaugh A.L., Bowman B.H., and Yang F. Expression and inflammatory regulation of haptoglobin gene in adipocytes. Biochem Biophys Res Commun 209 (1995) 250-256
48. Mihailović M., Dinić S., Uskoković A., et al. Acute-phase related binding ability of p53 for the hormone response element of the haptoglobin gene in adult rats. Cell Biol Int 29 (2005) 968-970
49. Awadallah S.M., and Atoum M.F. Haptoglobin polymorphism in breast cancer patients form Jordan. Clin Chim Acta 341 (2004) 17-21
50. Levy A.P., Larson M.G., Corey D., Lotan R., Vita J.A., and Benjamin E.J. Haptoglobin phenotype and prevalent coronary heart disease in the Framingham offspring cohort. Atherosclerosis 172 (2004) 361-365
51. Bacquer D.D., Backer G., Langlois M., Delanghe J., Kesteloot H., and Kornitzer M. Haptoglobin polymorphism as a risk factor for coronary heart disease mortality. Atherosclerosis 157 (2001) 161-166
52. Grinspoon S., and Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med 352 (2005) 48-62